Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Galectin Therapeutics Inc., explained in plain language.
This study tested a drug called belapectin to see if it could prevent the formation of enlarged veins in the throat (esophageal varices) in people with liver scarring from NASH. These veins can burst and cause life-threatening bleeding. The trial enrolled 357 adults with liver ci…
Phase: PHASE2, PHASE3 • Sponsor: Galectin Therapeutics Inc. • Aim: Prevention
Last updated May 14, 2026 12:02 UTC